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Botulism and Picrotoxin.
A. H. M a l o n e y .
From the Department o f Pharmacology, Howard University School o f Medicine,
Washington, D. C.
Two phases are differentiated in botulinal intoxication: (1) a 
period o f stimulation and (2 ) o f  respiratory depression. Experi­
ments with picrotoxin point to reciprocal potentiation during the 
phase o f botulinal stimulation and antagonism during the phase o f 
depression.
The botulinal toxin (type A )  in these experiments was prepared 
and supplied by the National Institute o f Health in Washington. 
Its potency was expressed in terms o f an intravenous mouse MLD, 
one unit being 0.00005 cc, the smallest amount that would kill a 17 
to 20 g mouse when injected intravenously.
These experiments were performed on healthy stock rabbits rang­
ing in weights from 1.45 to 1.85 kg.
Injected into the marginal ear vein 10,000 U (0.5 cc) o f  the 
toxin caused death (1 0 0 % ) within 13 hours average time. Three 
mg o f picrotoxin intravenously administered is surely convulsant 
and frequently lethal; 2 mg is usually convulsant but non-lethal; 
while 1 mg is never lethal, rarely convulsant but regularly hyper- 
stimulating to normal rabbits within this weight-range. However, 
when within the first hour following the injection o f botulinal toxin, 
3 mg, 2 mg, or 1 mg o f picrotoxin was injected into the vein or 
even the muscle all the animals died within the first 2 hours with 
severe convulsions. But when an interval o f  3 to 5 hours was al­
lowed to elapse between the time o f injection o f toxin and picro­
toxin with the picrotoxin divided into 0.1 mg doses each hour, sub-
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cutaneously, the life span was extended from an average o f  13 (con- 
trols) to 23 hours. (Table I-a.)
Intraabdominally, 20,000 U, 40,000 U, and 60,000 U, each o f 
botulinal toxin was 100% lethal in 5 hours (average time). When 
administered by this route and in these amounts there began to 
appear signs o f intoxication between the second and the third hour. 
When an interval o f 3 hours was allowed to elapse and 0.1 mg o f 
picrotoxin was given per hour, subcutaneously, the life span was 
increased from 5 hours (controls) to 15.9 hours. (Table I-b.)
Intravenously 20,000 U, 40,000 U, and 60,000 U, o f  botulinal 
toxin were in the aggregate 100% lethal in 1.8 hours, the signs o f 
intoxication being in evidence within the first 50 minutes. When 1 
mg picrotoxin was administered subcutaneously one hour after the 
botulinal toxin the life span was extended to 3 hours. Better still, 
when the dose o f picrotoxin was given as 0.2 mg each hour, subcu­
taneously, the life span was extended to 5.2 hours. (Table I-c.)
Small intravenous injections (10,000 U ) and large intraabdomi­
nal (20,000 U, 40,000 U, and 60,000 U ) injections o f  botulinal 
toxin produce a slow toxemia characterized by restlessness, manifest 
discomfort, listlessness interrupted by “ fits and starts” , jerky irreg­
ular respiration, definite dyspnea, gasping, falling over, very slow 
respiration, and death.
Large intravenous doses (20,000 U, 40,000 U, and 60,000 U ) 
produce rapid toxemia in which one observes hyperexcitability, mani­
fest discomfort, dyspnea, gasping, falling over, and death in pro­
found depression. In spite o f the gradualness as against the rapid­
ity o f appearance o f the symptoms in the 2 groups, both exhibit evi­
dences o f  the 2 distinct phases, vis., (1 )  stimulation, (2 )  depression. 
The second phase is ushered in by displays o f manifest discomfort. 
The animal seems unable to remain quietly for any length o f time 
in one place. Between intervals o f quiet he jumps about as though 
the air in his environment is being shut off. This marks the period 
o f  transition.
I f  picrotoxin is given during the phase o f stimulation its convul- 
sant action is markedly increased so that a dose which would ordi­
narily be sub-threshold to convulsions may become a fatally convul- 
sant dose. Here the 2 poisons definitely potentiate each other. If. 
however, picrotoxin is administered during the period o f transition 
or early in the phase o f depression they antagonize each other 
so that the impending embarrassment to the respiratory center is 
delayed.
The high mortality in botulinal poisoning is indicative o f  the lim­
itation o f our knowledge in handling this grave, but fortunately un­
common, condition. Bronfenbrenner and Weiss1 discovered that
i Bronfenbrenner, J. J., and Weiss, H., J. Exp. Med., 1924, 39, 517.
certain depressants so extended the latent period o f  the poison that 
the employment o f antitoxin could be postponed for hours provided 
that the animal was kept under the influence o f  ether anesthesia, 
luminal, nitrous oxide-oxygen or morphine. In acute poisoning 
delay is always desirable. Picrotoxin administered during the phase 
o f stimulation in botulinal intoxication enhances the toxicity o f the 
latter; but administered at intervals during the transition or the 
depressed phase in small amounts it antagonizes the toxic action o f  
botulinus and delays the terminal event.
